Domov › Rakovina močového mechúra › Illinois
Klinické štúdie Rakovina močového mechúra v štáte Illinois
30 štúdií pre Rakovina močového mechúra hľadá účastníkov v zariadeniach v štáte Illinois.
Mestá v štáte Illinois
- Chicago21 štúdií
- Cicero8 štúdií
- Evanston7 štúdií
- Joliet7 štúdií
- Decatur6 štúdií
- Springfield6 štúdií
- Naperville4 štúdií
- Peoria4 štúdií
- Bloomington4 štúdií
- Danville4 štúdií
- Champaign4 štúdií
- Charleston4 štúdií
- Arlington Heights3 štúdií
- Aurora3 štúdií
- Waukegan3 štúdií
- Galesburg3 štúdií
- North Peoria3 štúdií
Oficiálny text štúdie (anglicky)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Chicago Hospital, Chicago
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- University of Chicago Medical Center ( Site 5037), Chicago
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07232602Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Northwestern University, Chicago
- University of Illinois, Chicago
- Loyola University Medical Center, Maywood
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- a 54 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Rush MD Anderson Cancer Center, Chicago
- Carle at The Riverfront, Danville
- Cancer Care Specialists of Illinois - Decatur, Decatur
- a 11 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06770582A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06833073A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06172478Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Rush-Copley Medical Center, Aurora
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- a 38 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07061964Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Hope and Healing Clinical Research LLC, Hinsdale
- Hope and Healing Clinical Research LLC, New Lenox
- Illinois Cancer Specialists, Niles
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Carle at The Riverfront, Danville
- a 12 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Memorial Hospital, Shiloh
- Siteman Cancer Center - Shiloh, Shiloh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07421700A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07206225A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Chicago, Zion
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07277413DESTINY-PANTUMOUR04
- Research Site, Decatur
Prebieha náborObservačná štúdia
Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
- Endeavor Health, Evanston
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07218380Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Associated Urological Specialists, Chicago Ridge
- Uropartners, Glenview
- Accellacare, Lisle
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Comprehensive Urologic Care, Lake Barrington
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- The University of Chicago Medical Center (UCMC), Chicago
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT05614739Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Niles
- Research Site, Peoria
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07129993Measuring Surgical Recovery After Radical Cystectomy
- University of Chicago, Chicago
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT03193970Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- OSF Saint Anthony's Health Center, Alton
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- a 32 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07097142A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
- Accellacare - Deerfield, Deerfield
- a 5 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT04879329A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Ingalls Family Care Center, Calumet City
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- a 13 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT04389632Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
- Northwestern University, Chicago
- Northwestern Medicine Orland Park, Orland Park
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT06630416A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- The University of Chicago Comprehensive Cancer Center, Chicago
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT06778863Blue Light Cystoscopy With Cysview® Registry
- Northwestern University, Chicago
- Northshore University Health System, Evanston
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 12. 2025 · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
Prebieha náborObservačná štúdia
Vek 18 až 100 · Všetky pohlavia · Aktualizované 10. 10. 2025 · NCT06310759Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Prebieha nábor
Vek 65 a viac · Všetky pohlavia · Aktualizované 3. 10. 2025 · NCT06427824Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.